Stay updated with breaking news from Fabio fiallo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research report released on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Stock Performance NASDAQ ABIO opened at $3.22 on Monday. ARCA biopharma has a 12 month low of $1.56 and a 12 month high […] ....
StockNews.com started coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a report released on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Stock Down 6.9 % ARCA biopharma stock opened at $3.25 on Friday. ARCA biopharma has a 52-week low of $1.56 and a 52-week […] ....
StockNews.com started coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research note issued to investors on Saturday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Stock Up 4.6 % ARCA biopharma stock opened at $3.40 on Friday. ARCA biopharma has a 1-year low of $1.56 and […] ....
ARCA biopharma, Inc. (NASDAQ:ABIO – Get Free Report) saw some unusual options trading activity on Wednesday. Stock traders acquired 3,817 call options on the company. This is an increase of 10,216% compared to the typical daily volume of 37 call options. Institutional Trading of ARCA biopharma Hedge funds have recently added to or reduced their […] ....